- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT01948440
ASI-MV Solutions: A Tailored Program for Substance Abusers in Early Recovery
20 сентября 2013 г. обновлено: Emil Chiauzzi, Inflexxion, Inc.
Making referrals to medical and psychosocial services for substance abuse clients has proven difficult due to lack of access to services, inadequate counselor knowledge, and lack of motivation and skills among clients.
Inflexxion is proposing the development of ASI-MV Solutions, which will educate clients about employment, legal, psychiatric, relapse prevention, medical, and family issues, as well as include resources and strategies for counselors.
By linking learning modules to client results on the ASI-MV, an online interactive version of the ASI administered in treatment settings, we will be able to offer clients important tools to address key recovery issues and encourage counselors to make appropriate referrals to medical and psychosocial services.
Обзор исследования
Статус
Завершенный
Вмешательство/лечение
Подробное описание
Substance abuse research indicates that: (1) addressing medical and psychosocial problems associated with substance abuse and dependence leads to better outcomes; (2) treatments are now shorter due in part to rising healthcare costs, and it is difficult to address these issues effectively during treatment, making medical and psychosocial ("wraparound") services following treatment essential; (3) counselors may lack the knowledge to effectively integrate these services; and (4) referrals to these services have been underutilized and clients may lack the motivation, knowledge, or skills to follow up with the referrals when they are made.
To address these deficits, we are proposing the development of ASI-MV Solutions, which will provide tailored motivational feedback and skill-building lessons to clients to address specific psychosocial and medical problem areas.
We expect that ASI-MV Solutions will have seven modules (Alcohol, Drugs, Medical, Psychiatric, Legal, Employment, and Family) corresponding to domains of the ASI-MV, a Web-enabled interactive version of the ASI administered in treatment settings.
Substance abusers who have high severity scores on ASI-MV subscales will be directed to corresponding interactive lessons and local resources on ASI-MV Solutions.
To demonstrate the feasibility of the program concept, the Phase I study focused on the Employment domain.
All feasibility criteria were met and findings indicated: (1) Proposed content was based on highly positive findings from concept mapping, as well as usability and acceptance testing with clients and experts.
Ratings of potential effectiveness and appeal were high.
(2) Usability testing indicated that the program was usable by the target audience, the skills and outcomes were relevant to the target audience, and the program was regarded as potentially very helpful to the treatment process.
We surpassed feasibility benchmarks for both clients and experts.
(3) Our technical/design team produced a demonstration program that was perceived by key stakeholders as highly usable and engaging multimedia program, as well as determining the necessary technologies to produce the complete program in Phase II.
In Phase II we will develop ASI-MV Solutions content, complete the ASI-MV Solutions program, field test the program, and conduct satisfaction and acceptance testing of the program with clients and counselors.
Тип исследования
Интервенционный
Регистрация (Действительный)
39
Фаза
- Фаза 2
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Все
Описание
Inclusion Criteria:
- Client Inclusion Criteria. We will recruit participants in the same proportions as in usability testing - 40% female, 40% minorities. The inclusion criteria for clients are the same as those for usability testing, except that we will require the participant to provide: (1) the names of at least three contacts who can help locate the client during the study, and (2) multiple means of contacting them (telephone, mail, and/or email). As with usability participants, we will seek clients who are in the early stages of treatment (30 days or less, including new intakes).
Exclusion Criteria:
- None
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Профилактика
- Распределение: Нерандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: ASI-MV Solutions
The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions.
The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
The Experimental group will complete the ASI-MV and use the ASI-MV Solutions program for eight 30-minute sessions, followed by monthly booster sessions.
The Experimental group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
|
Без вмешательства: Treatment as Usual
The Control group participants will complete the ASI-MV and receive their normal course of treatment.
The Control group will undergo a baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention.
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
improved outcomes, as measured by substance use, psychosocial, and psychological functioning
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Addiction Severity Index - Multimedia Version (ASI-MV)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
|
greater problem-services matching, as measured by the number and fit of referred/received services
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Treatment Services Checklist (Client Version) and Treatment Services Checklist (Counselor Version).
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
|
greater treatment motivation
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES, Version 8D; Miller & Tonigan, 1996)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
|
greater self-efficacy in managing psychosocial issues
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Drug Avoidance Self-Efficacy Scale
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
treatment compliance
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Treatment Compliance: We will ask counselors to record scheduled and planned sessions within the treatment facility as a way of assessing treatment compliance.
We will also ask counselors to record client reasons for leaving treatment prematurely (Against Medical Advice, moving, hospitalization, etc.).
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
|
treatment alliance with counselors
Временное ограничение: baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Working Alliance Inventory-Short Form (Clients) and Working Alliance Inventory-Short Form (Counselors)
|
baseline assessment and one-month post-baseline, two-month post-baseline, and six-month post-intervention
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Спонсор
Следователи
- Главный следователь: Emil Chiauzzi, PhD, Inflexxion, Inc.
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования
1 июля 2010 г.
Первичное завершение (Действительный)
1 июля 2013 г.
Завершение исследования (Действительный)
1 июля 2013 г.
Даты регистрации исследования
Первый отправленный
27 июля 2010 г.
Впервые представлено, что соответствует критериям контроля качества
20 сентября 2013 г.
Первый опубликованный (Оценивать)
23 сентября 2013 г.
Обновления учебных записей
Последнее опубликованное обновление (Оценивать)
23 сентября 2013 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
20 сентября 2013 г.
Последняя проверка
1 сентября 2013 г.
Дополнительная информация
Термины, связанные с этим исследованием
Ключевые слова
Дополнительные соответствующие термины MeSH
Другие идентификационные номера исследования
- 2R44DA026232-02 (Грант/контракт NIH США)
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .